Home » PDL BioPharma to Sell Busulfex Rights for $200M
PDL BioPharma to Sell Busulfex Rights for $200M
Otsuka Pharmaceutical Co. Ltd. will acquire rights of a drug from PDL BioPharma Inc. for $200 million, the companies said Monday.
Silicon Valley/San Jose Business Journal
Silicon Valley/San Jose Business Journal
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May